News
News from us and our partners
Tags
Topics
0 results
- News
GlycoEra raises $130 million Series B for protein degraders
- News
Biotalys and AgroFresh partner on biological fungicides
- News
DMC Biotechnologies appoints K'Lynne Johnson as board chair
- News
BrightHeart gets third FDA clearance for B-Right Views AI
- News
AAVantgarde presents clinical data for Usher 1B at ARVO
- News
HAYA Therapeutics raises $65M in Series A funding
- News
Sitryx nominates SIT-047 for psoriatic arthritis
- News
Latent Labs and AWS partner to scale AI for life sciences
- News
BrightHeart gets FDA clearance for real-time tablet access
- News
SafeHeal closes €35M Series C to advance Colovac
- News
NodThera's NT-0796 enhances weight loss with GLP-1
- News
Abivax completes enrollment in Phase 3 obefazimod trials
- News
Rasmus Holm-Jorgensen appointed CFO at AAVantgarde
- News
Mainstay Medical announces exclusive coverage of ReActiv8® by Anthem Blue Cross/Blue Shield
- News
Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)